Prosecution Insights
Last updated: August 16, 2026

Roche Sequencing Solutions Inc.

25 pending office actions • 12 art units • 25 examiners • 0 of 25 (0%) have an AI response strategy ready • 20 patents granted in the last 365 days

Portfolio Summary

25
Total Pending OAs
18
Non-Final OAs
6
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 8 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

5
Overdue
0
Due this week
2
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 8 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (5)Due ≤ 30 days (2)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

14
Hard (56%)
8
Medium (32%)
3
Easy (12%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other5 (20%)
§103 only4 (16%)
§112 only1 (4%)
Double-patenting only2 (8%)
Double-patenting + other4 (16%)
Multi-statute (no §101)9 (36%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

22
Life Sciences
88% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
3
Business / Other
12% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

250 h
Manual time on pending OAs
50 h
Time saved (low, 20%)
88 h
Time saved (mid, 35%)
2.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KAUR, GURPREET 1 65.1% +36.2%
SWIFT, CANDICE LEE 1 57.4% +36.7%
LAU, JONATHAN S 1 63.9% -18.1%
BELLAH, JEFFREY LAWRENCE 1
KIM, YOUNG J 1 64.8% +18.0%
GREENE, CAROLYN LEE 1 64.9% +49.7%
BROWN, MINDY G 1 52.4% +47.5%
COHEN, BRIAN W 1 54.4% +47.8%
CROW, ROBERT THOMAS 1 41.7% +32.1%
SUN, CAITLYN MINGYUN 1 63.6% +11.1%

Hard Cases (14)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17905724 MAGNETIC SENSOR ARRAYS FOR NUCLEIC ACID SEQUENCING AND METHODS OF MAKING AND USING THEM LU, FRANK WEI MIN 59d overdue
18230398 NANOPORE FORMING METHOD AND USES THEREOF COHEN, BRIAN W 4d overdue
17352087 IDENTIFICATION OF GLOBAL SEQUENCE FEATURES IN WHOLE GENOME SEQUENCE DATA FROM CIRCULATING NUCLEIC ACID AUGER, NOAH ANDREW 8d
17346060 MONITORING MUTATIONS USING PRIOR KNOWLEDGE OF VARIANTS ROSSI, VY BUI 9d
18052337 MODULAR NUCLEIC ACID ADAPTERS BUNKER, AMY M 33d
18962946 DIFFERENTIAL OUTPUT OF ANALOG MEMORIES STORING NANOPORE MEASUREMENT SAMPLES KAUR, GURPREET
18542500 NUCLEOSIDE-5'-OLIGOPHOSPHATES HAVING A CATIONICALLY-MODIFIED NUCELOBASE LAU, JONATHAN S
18561986 ENHANCER OLIGONUCLEOTIDES FOR NUCLEIC ACID HYBRIDIZATION KIM, YOUNG J

Interview Candidates (8)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18230398 NANOPORE FORMING METHOD AND USES THEREOF COHEN, BRIAN W 4d overdue
18962946 DIFFERENTIAL OUTPUT OF ANALOG MEMORIES STORING NANOPORE MEASUREMENT SAMPLES KAUR, GURPREET
18712051 THERMOSTABLE POLYMERASE VARIANTS SWIFT, CANDICE LEE
18561986 ENHANCER OLIGONUCLEOTIDES FOR NUCLEIC ACID HYBRIDIZATION KIM, YOUNG J
18475498 IMMUME CELL COUNTING BASED ON IMMUNE REPERTOIRE SEQUENCING GREENE, CAROLYN LEE
18465724 TARGETED NEXT-GENERATION SEQUENCING VIA ANCHORED PRIMER EXTENSION BROWN, MINDY G
18348235 TRANSLOCATION CONTROL FOR SENSING BY A NANOPORE CROW, ROBERT THOMAS
18246009 DEVICES AND METHODS FOR URINE SAMPLE ANALYSIS SUN, CAITLYN MINGYUN

Top Art Units

Art UnitApps
1683 4
1681 4
1682 3
1795 2
1684 2
1657 1
1693 1
1759 1
1686 1
1687 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18962946 DIFFERENTIAL OUTPUT OF ANALOG MEMORIES STORING NANOPORE MEASUREMENT SAMPLES KAUR, GURPREET §102§103 Non-Final OA Pending Nov 27, 2024
18712051 THERMOSTABLE POLYMERASE VARIANTS SWIFT, CANDICE LEE 1657 §102§112DP Non-Final OA Pending May 21, 2024
18542500 NUCLEOSIDE-5'-OLIGOPHOSPHATES HAVING A CATIONICALLY-MODIFIED NUCELOBASE LAU, JONATHAN S 1693 §102§103§112 Non-Final OA Pending Dec 15, 2023
18535222 MOLECULAR DETECTION AND COUNTING USING NANOPORES BELLAH, JEFFREY LAWRENCE 1683 DP Non-Final OA Pending Dec 11, 2023
18561986 ENHANCER OLIGONUCLEOTIDES FOR NUCLEIC ACID HYBRIDIZATION KIM, YOUNG J 1681 §102§103§112 Non-Final OA Pending Nov 17, 2023
18475498 IMMUME CELL COUNTING BASED ON IMMUNE REPERTOIRE SEQUENCING GREENE, CAROLYN LEE 1681 §112 Non-Final OA Pending Sep 27, 2023
18465724 TARGETED NEXT-GENERATION SEQUENCING VIA ANCHORED PRIMER EXTENSION BROWN, MINDY G 1683 §101§102§103§112 Non-Final OA Pending Sep 12, 2023
18230398 NANOPORE FORMING METHOD AND USES THEREOF COHEN, BRIAN W 1759 §102§103§112Other Non-Final OA 4d overdue Pending Aug 04, 2023
18348235 TRANSLOCATION CONTROL FOR SENSING BY A NANOPORE CROW, ROBERT THOMAS 1682 §102§112DPOther Non-Final OA Pending Jul 06, 2023
18246009 DEVICES AND METHODS FOR URINE SAMPLE ANALYSIS SUN, CAITLYN MINGYUN 1795 §103 Non-Final OA Pending Mar 20, 2023
18113308 DEEP-LEARNING-BASED TECHNIQUES FOR GENERATING A CONSENSUS SEQUENCE FROM MULTIPLE NOISY SEQUENCES FONSECA LOPEZ, FRANCINI ALVARENGA §101§102§103 Non-Final OA Pending Feb 23, 2023
18058484 NANOPORE CELL WITH SEAMLESS WORKING ELECTRODE AND METHODS OF FORMING THE SAME GAMBLE JR, RANDALL LEE 1795 §103 Non-Final OA 138d overdue Pending Nov 23, 2022
18052337 MODULAR NUCLEIC ACID ADAPTERS BUNKER, AMY M 1684 §102§112 Non-Final OA 33d Pending Nov 03, 2022
18051619 SYSTEMS AND METHODS FOR USING TRAPPED CHARGE FOR BILAYER FORMATION AND PORE INSERTION IN A NANOPORE ARRAY SCHLOOP, ALLISON ELIZABETH 1683 §103§112 Non-Final OA Pending Nov 01, 2022
17905784 NOVEL NUCLEIC ACID TEMPLATE STRUCTURE FOR SEQUENCING GIAMMONA, FRANCESCA FILIPPA 1681 §102§103 Non-Final OA Pending Sep 07, 2022
17905724 MAGNETIC SENSOR ARRAYS FOR NUCLEIC ACID SEQUENCING AND METHODS OF MAKING AND USING THEM LU, FRANK WEI MIN 1683 §102§112 Final Rejection 59d overdue Pending Sep 06, 2022
17756068 SYSTEMS AND METHODS FOR CONTAMINATION DETECTION IN NEXT GENERATION SEQUENCING SAMPLES SMITH, EMILIE ALINE 1686 §101§112 Non-Final OA Pending May 16, 2022
17651135 SINGLE TUBE PREPARATION OF DNA AND RNA FOR SEQUENCING YU, TIAN NMN 1681 §103 Non-Final OA Pending Feb 15, 2022
17561626 INCREASING DYNAMIC RANGE FOR IDENTIFYING MULTIPLE EPITOPES IN CELLS YOUNG, BRIAN ELLIS 1684 §112DP Final Rejection 49d overdue Pending Dec 23, 2021
17595263 DEVICES AND METHODS FOR SAMPLE ANALYSIS DAUNER, JOSEPH G 1682 DP Final Rejection 46d overdue Pending Nov 12, 2021
17466292 PERIOD-TO-PERIOD ANALYSIS OF AC SIGNALS FROM NANOPORE SEQUENCING VANNI, GEORGE STEVEN §112DP Non-Final OA Pending Sep 03, 2021
17445284 METHODS, COMPOSITIONS, AND DEVICES FOR SOLID-STATE SYNTEHSIS OF EXPANDABLE POLYMERS FO RUSE IN SINGLE MOLECULE SEQUENCINGS HANEY, AMANDA MARIE 1682 §103 Final Rejection Pending Aug 17, 2021
17352087 IDENTIFICATION OF GLOBAL SEQUENCE FEATURES IN WHOLE GENOME SEQUENCE DATA FROM CIRCULATING NUCLEIC ACID AUGER, NOAH ANDREW 1687 §101§112 Final Rejection 8d Pending Jun 18, 2021
17350822 METHODS FOR DETECTING AN ANALYTE USING STRUCTURE SWITCHING BINDING AGENTS LIRIANO-NG, MELISSA LIZETTE 1677 §102§103 Final Rejection Pending Jun 17, 2021
17346060 MONITORING MUTATIONS USING PRIOR KNOWLEDGE OF VARIANTS ROSSI, VY BUI 1685 §101§102§103§112 Non-Final OA 9d Pending Jun 11, 2021

Managing Roche Sequencing Solutions Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month